Trial Profile
Evaluation of the efficacy and safety of Pyronaridine-Artesunate (Pyramax) with low-dose Primaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Salavanh province, Lao PDR
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Artesunate/pyronaridine (Primary) ; Primaquine (Primary)
- Indications Falciparum malaria; Vivax malaria
- Focus Therapeutic Use
- Acronyms TES
- 17 Aug 2018 New trial record